Cargando…
Health Care Costs for Patients with Heart Failure Escalate Nearly 3-Fold in Final Months of Life
BACKGROUND: Heart failure (HF) is a severe chronic disease with growing prevalence and health care burden as well as high mortality. End-of-life cost data for patients with HF may inform disease and medication therapy management. OBJECTIVES: To (a) characterize a real-world sample of patients with H...
Autores principales: | Obi, Engels N., Swindle, Jason P., Turner, Stuart J., Russo, Patricia A., Altan, Aylin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398255/ https://www.ncbi.nlm.nih.gov/pubmed/27882835 http://dx.doi.org/10.18553/jmcp.2016.22.12.1446 |
Ejemplares similares
-
Lower Hospitalization and Healthcare Costs With Sacubitril/Valsartan Versus Angiotensin‐Converting Enzyme Inhibitor or Angiotensin‐Receptor Blocker in a Retrospective Analysis of Patients With Heart Failure
por: Albert, Nancy M., et al.
Publicado: (2019) -
Impact of aggressive management and palliative care on cancer costs in the final month of life
por: Cheung, Matthew C., et al.
Publicado: (2015) -
Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report
por: Dell’Oro, Raffaella, et al.
Publicado: (2017) -
Real de-escalation or escalation in disguise?
por: Banys-Paluchowski, Maggie, et al.
Publicado: (2023) -
Bloodstream infections and sepsis in Greece: over-time change of epidemiology and impact of de-escalation on final outcome
por: Koupetori, Marina, et al.
Publicado: (2014)